Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $363.92 | $7.19 | 4,958.25% | 7,278.40x | 349.89x | 8.06x | 9.76x | 19.46x | $529.27M | 1.32% | $4.13B | 37.48 | $38.18B | 120.05 | ||
| CORT | CORCEPT THERAPEUTICS INC | $75.11 | $32.31 | 132.47% | 75.11x | 73.82x | 10.49x | 12.50x | 1.05x | $162.57M | 2.09% | $631.90M | 6.10 | $7.78B | 117.95 | ||
| NVO | NOVO NORDISK A S | $47.55 | $149.69 | -68.23% | 13.22x | 1.99x | 4.34x | 8.07x | 0.14x | $9.34B | 4.42% | $26.18B | 5.89 | $221.94B | 8.95 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $462.30 | $28.68 | 1,511.68% | 1,491.29x | 317.54x | 18.93x | 261.13x | 6.35x | $221.36M | 0.36% | $233.89M | 1.78 | $62.80B | 413.36 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.88 | $4.94 | -61.97% | 26.86x | 14.32x | 2.41x | 2.86x | 0.15x | -$11.69M | -7.82% | $52.91M | 0.67 | $145.72M | 16.43 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.70 | $11.18 | -13.25% | 20.21x | 7.91x | 6.43x | 4.10x | 0.43x | -$23.64M | -4.36% | $133.17M | 2.38 | $554.36M | 8.25 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $41.28 | $14.96 | 176.00% | 84.24x | 39.01x | 5.16x | 5.84x | 1.26x | $101.73M | 3.30% | $535.38M | 7.17 | $2.96B | 55.32 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $207.05 | $60.86 | 240.23% | 89.63x | 29.57x | 16.14x | 4.29x | 1.61x | $30.76M | 0.76% | $950.17M | 48.53 | $4.39B | 42.58 | ||
| GMAB | GENMAB A | $30.32 | $113.37 | -73.26% | 12.94x | 1.75x | 5.46x | 3.39x | 0.11x | $1.19B | 6.13% | $5.75B | 8.96 | $17.85B | 8.92 | ||
| ARGX | ARGENX SE | $918.53 | $255.21 | 259.91% | 36.71x | 54.89x | 29,630.00x | 7.82x | 3.07x | $467.72M | 0.83% | $7.17B | 117.50 | $53.66B | 66.14 | ||
| VCEL | VERICEL CORP | $39.03 | $7.20 | 441.84% | 150.12x | 173.93x | 7.62x | 6.13x | 2.53x | $20.38M | 1.04% | $321.86M | 6.38 | $1.97B | 67.26 | ||
| RPRX | ROYALTY PHARMA PLC | $39.46 | $41.27 | -4.38% | 22.42x | 8.61x | 7.25x | 2.37x | 0.47x | $2.11B | 12.39% | $9.62B | 22.28 | $30.78B | 29.48 | ||
| KRYS | KRYSTAL BIOTECH INC | $204.74 | $83.19 | 146.12% | 29.67x | 40.19x | 15.88x | 5.22x | 1.75x | $166.02M | 2.80% | $1.14B | 39.30 | $5.55B | 28.73 | ||
| TECH | BIO-TECHNE CORP | $58.15 | $16.10 | 261.28% | 116.30x | 28.45x | 7.43x | 4.61x | 1.63x | $224.06M | 2.48% | $1.97B | 12.65 | $9.31B | 42.15 | ||
| CRMD | CORMEDIX INC | $10.08 | $16.46 | -38.78% | 4.44x | 4.75x | 3.57x | 2.12x | 1.12x | $74.42M | 9.73% | $374.13M | 4.93 | $894.23M | 7.97 | ||
| HALO | HALOZYME THERAPEUTICS INC | $70.10 | $76.14 | -7.94% | 14.34x | 11.16x | 6.61x | 16.36x | 0.54x | $602.40M | 7.33% | $503.92M | 4.30 | $9.33B | 11.04 | ||
| MDXG | MIMEDX GROUP INC | $6.72 | $3.58 | 87.77% | 24.00x | 15.50x | 2.53x | 4.17x | 1.27x | $66.82M | 6.71% | $238.95M | 1.61 | $871.38M | 12.59 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.67 | $0.85 | 807.25% | 109.57x | 72.77x | 6.49x | 7.25x | 6.43x | $3.05M | 0.44% | $101.92M | 1.12 | $699.64M | 52.89 | ||
| VCYT | VERACYTE INC | $38.76 | $8.81 | 339.99% | 99.38x | 97.02x | 6.16x | 2.44x | 2.18x | $98.21M | 3.22% | $1.26B | 15.98 | $2.79B | 48.90 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.16 | $41.54 | 30.39% | 19.91x | 17.83x | 3.36x | 1.72x | 0.78x | $832.13M | 8.00% | $6.06B | 31.54 | $9.75B | 12.62 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $435.52 | $171.26 | 154.31% | 30.43x | 23.70x | 9.50x | 6.38x | 1.82x | $3.34B | 3.00% | $17.32B | 67.76 | $107.39B | 23.04 | ||
| INCY | INCYTE CORP | $103.89 | $66.32 | 56.65% | 17.20x | 14.91x | 4.22x | 4.39x | 1.22x | $1.20B | 5.89% | $4.65B | 23.77 | $17.97B | 10.68 | ||
| ADMA | ADMA BIOLOGICS INC | $15.69 | $9.20 | 70.47% | 17.83x | 25.93x | 7.66x | 8.66x | 1.41x | $40.73M | 1.09% | $431.19M | 1.81 | $3.75B | 21.77 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.99 | $39.28 | -13.47% | 10.52x | 10.40x | 2.37x | 2.34x | 0.61x | $296.89M | 15.18% | $835.12M | 14.51 | $1.48B | 5.49 | ||
| INVA | INNOVIVA INC | $21.87 | $18.02 | 21.35% | 11.57x | 18.38x | 3.89x | 1.62x | 1.14x | $196.54M | 13.01% | $1.01B | 14.63 | $1.42B | 6.59 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.50 | $7.07 | 119.30% | 26.72x | 23.44x | 7.68x | 5.59x | 1.54x | $119.87M | 5.86% | $365.77M | 2.78 | $2.05B | 19.79 | ||
| EXEL | EXELIXIS INC | $42.65 | $26.99 | 58.02% | 17.34x | 17.79x | 5.00x | 5.29x | 1.24x | $779.77M | 6.81% | $2.16B | 8.05 | $11.24B | 12.11 | ||
| MNKD | MANNKIND CORP | $5.06 | $1.26 | 300.12% | 50.60x | 53.43x | 4.95x | -34.88x | 2.72x | $43.39M | 2.79% | -$44.55M | -0.15 | $1.79B | 24.41 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $725.34 | $346.42 | 109.38% | 16.69x | 16.96x | 5.27x | 2.46x | 2.82x | $4.22B | 5.62% | $30.96B | 298.82 | $76.43B | 13.38 | ||
| UTHR | UNITED THERAPEUTICS CORP | $476.59 | $192.09 | 148.11% | 16.73x | 16.97x | 6.67x | 3.11x | 6.47x | $1.12B | 5.37% | $6.59B | 150.46 | $19.18B | 10.82 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $22.66 | $10.75 | 110.70% | 12.66x | 15.24x | 4.80x | 3.03x | 21.37x | $234.54M | 8.44% | $920.25M | 7.51 | $2.10B | 6.48 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.